Your browser doesn't support javascript.
loading
SIRVVD model-based verification of the effect of first and second doses of COVID-19/SARS-CoV-2 vaccination in Japan.
Omae, Yuto; Kakimoto, Yohei; Sasaki, Makoto; Toyotani, Jun; Hara, Kazuyuki; Gon, Yasuhiro; Takahashi, Hirotaka.
Afiliación
  • Omae Y; College of Industrial Technology, Nihon University, Izumi, Narashino, Chiba, Japan.
  • Kakimoto Y; College of Industrial Technology, Nihon University, Izumi, Narashino, Chiba, Japan.
  • Sasaki M; College of Industrial Technology, Nihon University, Izumi, Narashino, Chiba, Japan.
  • Toyotani J; College of Industrial Technology, Nihon University, Izumi, Narashino, Chiba, Japan.
  • Hara K; College of Industrial Technology, Nihon University, Izumi, Narashino, Chiba, Japan.
  • Gon Y; Nihon University School of Medicine, Ooyaguchi, Itabashi, Tokyo, Japan.
  • Takahashi H; Research Center for Space Science, Advanced Research Laboratories, Tokyo City University, Todoroki, Setagaya, Tokyo, Japan.
Math Biosci Eng ; 19(1): 1026-1040, 2022 01.
Article en En | MEDLINE | ID: mdl-34903024
ABSTRACT
As of August 2021, COVID-19 is still spreading in Japan. Vaccination, one of the key measures to bring COVID-19 under control, began in February 2021. Previous studies have reported that COVID-19 vaccination reduces the number of infections and mortality rates. However, simulations of spreading infection have suggested that vaccination in Japan is insufficient. Therefore, we developed a susceptible-infected-recovered-vaccination1-vaccination2-death model to verify the effect of the first and second vaccination doses on reducing the number of infected individuals in Japan; this includes an infection simulation. The results confirm that appropriate vaccination measures will sufficiently reduce the number of infected individuals and reduce the mortality rate.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: COVID-19 Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Math Biosci Eng Año: 2022 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: COVID-19 Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Math Biosci Eng Año: 2022 Tipo del documento: Article País de afiliación: Japón